- Report
- September 2023
- 100 Pages
Global
From €5717EUR$5,950USD£4,916GBP
- Report
- January 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1441EUR$1,500USD£1,239GBP
- Report
- November 2023
- 75 Pages
United States
From €3363EUR$3,500USD£2,892GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,652GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1201EUR$1,250USD£1,033GBP
- Report
- October 2023
- 190 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,197GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,197GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,197GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,264GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,264GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,264GBP
- Report
- November 2020
- 120 Pages
Global
From €2402EUR$2,500USD£2,066GBP
- Clinical Trials
- June 2020
- 183 Pages
Global
From €2402EUR$2,500USD£2,066GBP
- Drug Pipelines
- November 2020
- 196 Pages
Global
From €1922EUR$2,000USD£1,652GBP
- Report
- September 2022
- 104 Pages
Global
From €1922EUR$2,000USD£1,652GBP
- Report
- May 2022
- 37 Pages
Global
From €1922EUR$2,000USD£1,652GBP
Aspergillosis is a type of fungal infection caused by the Aspergillus fungus. It can affect the lungs, sinuses, and other organs. Treatment for aspergillosis typically involves antifungal medications. The Aspergillosis Drug market is a subset of the larger Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. Aspergillosis drugs are used to treat a variety of forms of the infection, including allergic bronchopulmonary aspergillosis, chronic pulmonary aspergillosis, and invasive aspergillosis. These drugs are typically administered orally or intravenously.
Some companies in the Aspergillosis Drug market include Merck & Co., Pfizer, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more